Literature DB >> 15793160

Functional characterization of OXA-57, a class D beta-lactamase from Burkholderia pseudomallei.

Karen E Keith1, Petra C Oyston, Ben Crossett, Neil F Fairweather, Richard W Titball, Timothy R Walsh, Katherine A Brown.   

Abstract

Class D beta-lactamase OXA-57 was identified in a range of isolates of Burkholderia pseudomallei and Burkholderia thailandensis. Comparative kinetic analyses of wild-type and mutant forms of B. pseudomallei OXA-57 are reported. Implications of these data for beta-lactam resistance and the proposed role of Ser-104 in beta-lactam hydrolysis are discussed.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15793160      PMCID： PMC1068585          DOI： 10.1128/AAC.49.4.1639-1641.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  High-resolution X-ray structure of an acyl-enzyme species for the class D OXA-10 beta-lactamase.

Authors:  Laurent Maveyraud; Dasantila Golemi-Kotra; Akihiro Ishiwata; Oussama Meroueh; Shahriar Mobashery; Jean-Pierre Samama
Journal:  J Am Chem Soc       Date:  2002-03-20       Impact factor: 15.419

2.  Cloning and expression of class A beta-lactamase gene blaA(BPS) in Burkholderia pseudomallei.

Authors:  Terence K M Cheung; P L Ho; Patrick C Y Woo; K Y Yuen; P Y Chau
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

3.  Crystal structure of the class D beta-lactamase OXA-10.

Authors:  M Paetzel; F Danel; L de Castro; S C Mosimann; M G Page; N C Strynadka
Journal:  Nat Struct Biol       Date:  2000-10

4.  Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei.

Authors:  Matthew T G Holden; Richard W Titball; Sharon J Peacock; Ana M Cerdeño-Tárraga; Timothy Atkins; Lisa C Crossman; Tyrone Pitt; Carol Churcher; Karen Mungall; Stephen D Bentley; Mohammed Sebaihia; Nicholas R Thomson; Nathalie Bason; Ifor R Beacham; Karen Brooks; Katherine A Brown; Nat F Brown; Greg L Challis; Inna Cherevach; Tracy Chillingworth; Ann Cronin; Ben Crossett; Paul Davis; David DeShazer; Theresa Feltwell; Audrey Fraser; Zahra Hance; Heidi Hauser; Simon Holroyd; Kay Jagels; Karen E Keith; Mark Maddison; Sharon Moule; Claire Price; Michael A Quail; Ester Rabbinowitsch; Kim Rutherford; Mandy Sanders; Mark Simmonds; Sirirurg Songsivilai; Kim Stevens; Sarinna Tumapa; Monkgol Vesaratchavest; Sally Whitehead; Corin Yeats; Bart G Barrell; Petra C F Oyston; Julian Parkhill
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-17       Impact factor: 11.205

5.  Characterization of a laboratory-generated variant of BPS beta-lactamase from Burkholderia pseudomallei that hydrolyses ceftazidime.

Authors:  P L Ho; Terence K M Cheung; W C Yam; K Y Yuen
Journal:  J Antimicrob Chemother       Date:  2002-11       Impact factor: 5.790

6.  Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species.

Authors:  P J Brett; D DeShazer; D E Woods
Journal:  Int J Syst Bacteriol       Date:  1998-01

7.  Insights into class D beta-lactamases are revealed by the crystal structure of the OXA10 enzyme from Pseudomonas aeruginosa.

Authors:  L Maveyraud; D Golemi; L P Kotra; S Tranier; S Vakulenko; S Mobashery; J P Samama
Journal:  Structure       Date:  2000-12-15       Impact factor: 5.006

Review 8.  Melioidosis: review and update.

Authors:  A Leelarasamee; S Bovornkitti
Journal:  Rev Infect Dis       Date:  1989 May-Jun

9.  Cloning of the class D beta-lactamase gene from Burkholderia pseudomallei and studies on its expression in ceftazidime-susceptible and -resistant strains.

Authors:  Pannika Niumsup; Vanaporn Wuthiekanun
Journal:  J Antimicrob Chemother       Date:  2002-10       Impact factor: 5.790

10.  Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition.

Authors:  Chanwit Tribuddharat; Richard A Moore; Patricia Baker; Donald E Woods
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191
View more
  11 in total

Review 1.  Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.

Authors:  Herbert P Schweizer
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

2.  In Vitro Antibacterial Activity and In Vivo Efficacy of Sulbactam-Durlobactam against Pathogenic Burkholderia Species.

Authors:  Krisztina M Papp-Wallace; Adam B Shapiro; Scott A Becka; Elise T Zeiser; John J LiPuma; Douglas J Lane; Rekha G Panchal; John P Mueller; John P O'Donnell; Alita A Miller
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

3.  Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.

Authors:  Julia V Bugrysheva; David Sue; Jay E Gee; Mindy G Elrod; Alex R Hoffmaster; Linnell B Randall; Sunisa Chirakul; Apichai Tuanyok; Herbert P Schweizer; Linda M Weigel
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

4.  Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei.

Authors:  I-Ching Sam; Kah Heng See; Savithri D Puthucheary
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

Review 5.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

6.  Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei.

Authors:  Drew A Rholl; Krisztina M Papp-Wallace; Andrew P Tomaras; Michael L Vasil; Robert A Bonomo; Herbert P Schweizer
Journal:  Front Microbiol       Date:  2011-07-01       Impact factor: 5.640

7.  Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of β-lactam-resistant isolates.

Authors:  Shirley Hii Yi Fen; Sarunporn Tandhavanant; Rungnapa Phunpang; Peeraya Ekchariyawat; Natnaree Saiprom; Claire Chewapreecha; Rathanin Seng; Ekkachai Thiansukhon; Chumpol Morakot; Narongchai Sangsa; Sunee Chayangsu; Somchai Chuananont; Kittisak Tanwisaid; Wirayut Silakun; Noppol Buasi; Seksan Chaisuksant; Tanin Hompleum; Ploenchan Chetchotisakd; Nicholas P J Day; Wasun Chantratita; Ganjana Lertmemongkolchai; T Eoin West; Narisara Chantratita
Journal:  Antimicrob Agents Chemother       Date:  2021-02-16       Impact factor: 5.191

8.  Genomic comparison and phenotypic profiling of small colony variants of Burkholderia pseudomallei.

Authors:  Noorfatin Jihan Zulkefli; Cindy Shuan Ju Teh; Vanitha Mariappan; Soo Tein Ngoi; Jamuna Vadivelu; Sasheela Ponnampalavanar; Lay Ching Chai; Chun Wie Chong; Ivan Kok Seng Yap; Kumutha Malar Vellasamy
Journal:  PLoS One       Date:  2021-12-15       Impact factor: 3.240

9.  An improved selective culture medium enhances the isolation of Burkholderia pseudomallei from contaminated specimens.

Authors:  Andrew Goodyear; Linda Strange; Drew A Rholl; Joy Silisouk; David A B Dance; Herbert P Schweizer; Steven Dow
Journal:  Am J Trop Med Hyg       Date:  2013-09-23       Impact factor: 2.345

10.  A DUF4148 family protein produced inside RAW264.7 cells is a critical Burkholderia pseudomallei virulence factor.

Authors:  Susan Welkos; Irma Blanco; Udoka Okaro; Jennifer Chua; David DeShazer
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.